Carma HoldCo Inc. has broadened its European presence. Medical cannabis products from Tyson 2.0 are now available to patients in Germany via its exclusive partnership with Phcann International.
Mike Tyson, co-founder and Chief Brand Officer, commented: "It's incredible to see Tyson 2.0 expanding across Europe. Our goal has always been to provide the best cannabis products to those who need them most. This launch in Germany is a significant achievement in our mission to reach more consumers globally."
The launch will introduce three strains – Haymaker Haze, NYC Diesel, and Tiger Milk. Patients can now conveniently obtain prescriptions and access these premium products from their homes via telemedicine platforms and online pharmacies. The initial products will be supplied to pharmacies by Nimbus Health.
Adam Wilks, Chairman of Carma, remarked, "The launch of Tyson 2.0 in Germany marks a pivotal milestone in our European market strategy. As the parent company of Tyson 2.0, Carma is committed to broadening its global reach through strategic partnerships and delivering exceptional products. This move aligns with our mission to lead the market and reinforces our commitment to providing top-tier medical cannabis to patients in need."
Yuval Soiref, Co Founder of Phcann International, stated: "Partnering with Mike Tyson and the Tyson 2.0 Team, we are set to revolutionize access to medical cannabis in Germany. Our patients will benefit from the unparalleled convenience and comfort of being able to obtain their prescriptions and access our high-quality products from their homes through our partner telemedicine platforms and online pharmacies, ensuring they receive the best care possible."
Sasho Stefanoski, CEO of Phcann International, added: "We are thrilled to present Tyson 2.0 to patients in Germany. This launch represents a significant milestone for Phcann International and underscores our commitment to providing patients with premium cannabis products, from flowers to vapes."
For more information:
Tyson 2.0
tyson20.com